Skip to main content
ALLURION TECHNOLOGIES, INC. logo

ALLURION TECHNOLOGIES, INC. — Investor Relations & Filings

Ticker · ALUR ISIN · US02008G1022 US Human health and social work activities
Filings indexed 303 across all filing types
Latest filing 2025-08-21 Interim / Quarterly Rep…
Country US United States of America
Listing US ALUR

About ALLURION TECHNOLOGIES, INC.

https://www.allurion.com/en

Allurion Technologies, Inc. is a company focused on ending obesity through its comprehensive weight-loss platform, the Allurion Program. The program's core component is a procedure-less, swallowable gastric balloon that is placed during an outpatient visit and passes naturally after approximately four months. This device is integrated into a full-stack solution that includes a digital ecosystem for real-time progress tracking via connected devices, an AI-powered coaching assistant, and personalized support from a multidisciplinary team of healthcare professionals. The platform is designed to promote sustainable, metabolically healthy weight loss by combining appetite regulation with behavioral change support. It can function as a standalone treatment or in combination with other therapies, including the company's AI-native compounded GLP-1 program.

Recent filings

Filing Released Lang Actions
424B3
Interim / Quarterly Report Classification · 100% confidence The document is a Form 10-Q Quarterly Report filed by Allurion Technologies, Inc. for the quarterly period ended June 30, 2025. It includes restated financial statements, management's discussion and analysis, controls and procedures, and other comprehensive financial information typical of a quarterly report. The document is lengthy (15,000 characters) and contains substantive financial data and analysis, not just an announcement or certification. Therefore, it fits the definition of an Interim / Quarterly Report (IR).
2025-08-21 English
10-Q
Interim / Quarterly Report Q2 2025
2025-08-19 English
10-Q/A
Interim / Quarterly Report Q1 2025
2025-08-19 English
10-K/A
Annual Report FY 2024
2025-08-19 English
424B3
Regulatory Filings Classification · 95% confidence The document is a Form 8-K Current Report filed pursuant to the Securities Exchange Act of 1934. It details the Audit Committee's conclusion that previously issued financial statements should no longer be relied upon due to accounting errors related to fair value measurements of certain financial instruments. It discusses restatements of prior financial reports including the Annual Report on Form 10-K and Quarterly Reports on Form 10-Q. The document does not contain the full restated financial statements but announces the intention to file amendments to those reports. It also includes management's assessment of internal controls and disclosure controls. The document is primarily an announcement of accounting issues and restatements, not the restated financial reports themselves. Therefore, it is best classified as a Regulatory Filing (RNS) because it is a current report disclosing material information about financial restatements and internal control issues, but it is not the full Annual Report or Quarterly Report itself.
2025-08-15 English
NT 10-Q
Regulatory Filings Classification · 100% confidence The document is a Form 12b-25 filed with the SEC, which is a Notification of Late Filing. It specifically states that the company, Allurion Technologies, Inc., is unable to file its Quarterly Report on Form 10-Q for the quarter ended June 30, 2025, by the due date and requests additional time. The document provides reasons for the delay, including the need to restate prior financial statements due to accounting errors. It includes preliminary financial estimates but does not contain the actual financial statements or substantive financial data of the 10-Q report itself. The document is a regulatory notification about the delay in filing a report rather than the report itself. According to the classification rules, such a notification is best classified under Regulatory Filings (RNS) as it is a compliance document notifying the SEC and investors of the late filing and reasons for it, not the actual quarterly report or financial statements.
2025-08-15 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.